Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124447682 | 12444768 | 2 | F | 2006 | 20160602 | 20160607 | 20160804 | PER | US-ASTRAZENECA-2016SE45922 | ASTRAZENECA | 59.00 | YR | F | Y | 102.10000 | KG | 20160804 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124447682 | 12444768 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 2 MG, ONCE A WEEK, VIAL | 22200 | ||||||||||
| 124447682 | 12444768 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 2 MG, ONCE A WEEK, PEN | FF0125 | 22200 | |||||||||
| 124447682 | 12444768 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 0 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 124447682 | 12444768 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 0 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 124447682 | 12444768 | 5 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | DAILY | 0 | ||||||||||
| 124447682 | 12444768 | 6 | C | AFRIN | OXYMETAZOLINE | 1 | Nasal | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124447682 | 12444768 | 1 | Type 2 diabetes mellitus |
| 124447682 | 12444768 | 2 | Type 2 diabetes mellitus |
| 124447682 | 12444768 | 3 | Type 2 diabetes mellitus |
| 124447682 | 12444768 | 4 | Type 2 diabetes mellitus |
| 124447682 | 12444768 | 5 | Multiple allergies |
| 124447682 | 12444768 | 6 | Multiple allergies |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124447682 | 12444768 | Circumstance or information capable of leading to medication error | |
| 124447682 | 12444768 | Injection site extravasation | |
| 124447682 | 12444768 | Nodule | |
| 124447682 | 12444768 | Product packaging issue | |
| 124447682 | 12444768 | Weight decreased | |
| 124447682 | 12444768 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124447682 | 12444768 | 1 | 201504 | 201602 | 0 | |
| 124447682 | 12444768 | 2 | 201602 | 0 | ||
| 124447682 | 12444768 | 3 | 2006 | 0 | ||
| 124447682 | 12444768 | 4 | 201504 | 0 |